196 related articles for article (PubMed ID: 19408347)
21. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.
Jiao X; Yu W; Qian J; Chen Y; Wei P; Fang W; Yu G
BMC Cancer; 2018 May; 18(1):570. PubMed ID: 29776401
[TBL] [Abstract][Full Text] [Related]
22. ADAMs and ADAMTSs in cancer.
Turner SL; Blair-Zajdel ME; Bunning RA
Br J Biomed Sci; 2009; 66(2):117-28. PubMed ID: 19637655
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional domain architecture of the ADAM family proteinases.
Takeda S
Semin Cell Dev Biol; 2009 Apr; 20(2):146-52. PubMed ID: 18706512
[TBL] [Abstract][Full Text] [Related]
24. ADAM Metalloproteinases as Potential Drug Targets.
Camodeca C; Cuffaro D; Nuti E; Rossello A
Curr Med Chem; 2019; 26(15):2661-2689. PubMed ID: 29589526
[TBL] [Abstract][Full Text] [Related]
25. ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers.
Charrier L; Yan Y; Driss A; Laboisse CL; Sitaraman SV; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G346-53. PubMed ID: 15358598
[TBL] [Abstract][Full Text] [Related]
26. Expression patterns of the ADAMs in early developing chicken cochlea.
Lin J; Yan X; Wang C; Talabattula VA; Guo Z; Rolfs A; Luo J
Dev Growth Differ; 2013 Apr; 55(3):368-76. PubMed ID: 23496030
[TBL] [Abstract][Full Text] [Related]
27. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
Schwettmann L; Wehmeier M; Jokovic D; Aleksandrova K; Brand K; Manns MP; Lichtinghagen R; Bahr MJ
J Hepatol; 2008 Aug; 49(2):243-50. PubMed ID: 18490073
[TBL] [Abstract][Full Text] [Related]
28. Quantitative and dynamic expression profile of premature and active forms of the regional ADAM proteins during chicken brain development.
Markus A; Yan X; Rolfs A; Luo J
Cell Mol Biol Lett; 2011 Sep; 16(3):431-51. PubMed ID: 21786032
[TBL] [Abstract][Full Text] [Related]
29. Expression and relationship of male reproductive ADAMs in mouse.
Kim T; Oh J; Woo JM; Choi E; Im SH; Yoo YJ; Kim DH; Nishimura H; Cho C
Biol Reprod; 2006 Apr; 74(4):744-50. PubMed ID: 16407499
[TBL] [Abstract][Full Text] [Related]
30. ADAMs family in kidney physiology and pathology.
Zhu H; Wang J; Nie W; Armando I; Han F
EBioMedicine; 2021 Oct; 72():103628. PubMed ID: 34653870
[TBL] [Abstract][Full Text] [Related]
31. The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review.
Arai J; Otoyama Y; Nozawa H; Kato N; Yoshida H
Oncogene; 2023 Feb; 42(8):549-558. PubMed ID: 36572816
[TBL] [Abstract][Full Text] [Related]
32. ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview.
Takeda S
Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196928
[TBL] [Abstract][Full Text] [Related]
33. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
[TBL] [Abstract][Full Text] [Related]
34. The ADAMs family of proteins: from basic studies to potential clinical applications.
Duffy MJ; Lynn DJ; Lloyd AT; O'Shea CM
Thromb Haemost; 2003 Apr; 89(4):622-31. PubMed ID: 12669115
[TBL] [Abstract][Full Text] [Related]
35. A disintegrin and metalloprotease-10 is correlated with disease activity and mediates monocyte migration and adhesion in rheumatoid arthritis.
Isozaki T; Ishii S; Nishimi S; Nishimi A; Oguro N; Seki S; Miura Y; Miwa Y; Oh K; Toyoshima Y; Nakamura M; Inagaki K; Kasama T
Transl Res; 2015 Sep; 166(3):244-53. PubMed ID: 25796462
[TBL] [Abstract][Full Text] [Related]
36. Considerations on inhibition approaches for proinflammatory functions of ADAM proteases.
Dreymueller D; Ludwig A
Platelets; 2017 Jun; 28(4):354-361. PubMed ID: 27460023
[TBL] [Abstract][Full Text] [Related]
37. The ADAMs family: coordinators of nervous system development, plasticity and repair.
Yang P; Baker KA; Hagg T
Prog Neurobiol; 2006 Jun; 79(2):73-94. PubMed ID: 16824663
[TBL] [Abstract][Full Text] [Related]
38. Expression and cellular localization of metalloproteases ADAMs in high graded carotid artery lesions.
Pelisek J; Pongratz J; Deutsch L; Reeps C; Stadlbauer T; Eckstein HH
Scand J Clin Lab Invest; 2012 Dec; 72(8):648-56. PubMed ID: 23101757
[TBL] [Abstract][Full Text] [Related]
39. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
[TBL] [Abstract][Full Text] [Related]
40. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.
Karan D; Lin FC; Bryan M; Ringel J; Moniaux N; Lin MF; Batra SK
Int J Oncol; 2003 Nov; 23(5):1365-71. PubMed ID: 14532978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
